Strem Chemicals
United States Updated 9 July 2026
Strem Chemicals is an API manufacturer based in United States. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Its most recent recorded inspection, by US FDA, closed on 30 July 2025 as OAI.
2
registered plants
1 with an FDA FEI number
0
filings
across 0 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
7 of 7 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.
Inspection history
- 30 July 2025 OAI US FDA
- 27 January 2020 NAI US FDA
- 21 September 2017 VAI US FDA
- 24 March 2016 VAI US FDA
- 18 April 2014 VAI US FDA
- 9 December 2011 VAI US FDA
- 25 February 2010 VAI US FDA
NAI means no action indicated, VAI means voluntary action indicated, and OAI means
official action indicated.
Registered plants
| Site | FDA FEI |
| Newburyport, United States | Not on file |
| Newburyport, United States | 1220700 |
What they file, and where
| Molecule | Regulators | Docs |
| Carboplatin | US FDA | 1 |
| Cisplatin | US FDA | 1 |
Also appears on these molecule pages
Comparing suppliers?
Choose your molecules and target markets. Strem Chemicals comes back tiered against every other
supplier able to file there.
Start for free No sales call.
Open risk flags
- The most recent inspection outcome was OAI, on 30 July 2025.
Sources on this page
- FDA
- Drug master files, establishment registration, inspection classifications
- EDQM
- Certificates of suitability